Bio-Techne Corporation Operating Income for the Trailing 12 Months (TTM) ending March 31, 2025: USD 171.94 M

Bio-Techne Corporation Operating Income is USD 171.94 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -32.68% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.
  • Bio-Techne Corporation Operating Income for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 255.39 M, a -10.39% change year over year.
  • Bio-Techne Corporation Operating Income for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 284.99 M, a 0.14% change year over year.
  • Bio-Techne Corporation Operating Income for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 284.60 M, a 36.81% change year over year.
  • Bio-Techne Corporation Operating Income for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 208.02 M, a 28.91% change year over year.
Key Data
Date Operating Income EBIT EBITDA Net Income